The Newcastle Fibrosis Research Group is a leading multi-disciplinary research group at Newcastle University, renowned for its extensive expertise in the underlying mechanisms of fibrosis across various organs, including the liver, lung, kidney, heart, skin, and joints. The Newcastle Fibrosis Research Group's laboratory is dedicated to the discovery of molecules and molecular processes that govern the formation, maintenance, and degradation of scars in diseased solid organs, with a particular focus on the biology of myofibroblasts, the major cellular regulators of fibrosis. The Group's primary address is at Newcastle University, Newcastle Upon Tyne, Newcastle NE24HH, GB.
The Newcastle Fibrosis Research Group prides itself on its national and international collaborations, fostering trustful and fruitful relationships with both public and private entities within diverse research projects. This collaborative approach enhances the impact and reach of the Group's innovative research, contributing significantly to advancements in fibrosis research. The Newcastle Fibrosis Research Group remains at the forefront of understanding and combating fibrosis through cutting-edge research and collaborative efforts.
With a strong commitment to excellence and innovation, The Newcastle Fibrosis Research Group continues to drive progress in the field of fibrosis research. Through ongoing research and collaboration, the Group aims to develop effective treatments and therapies for fibrotic diseases, improving the lives of patients worldwide. We invite the manager of The Newcastle Fibrosis Research Group to create a customized and exclusive company showcase and product listing on our platform to further amplify your visibility and impact.
Le Newcastle Fibrosis Research Group est un groupe de recherche multidisciplinaire de premier plan de l'Université de Newcastle, réputé pour sa vaste expertise dans les mécanismes sous-jacents de la fibrose dans divers organes, notamment le foie, les poumons, les reins, le cœur, la peau et les articulations. Le laboratoire du Newcastle Fibrosis Research Group se consacre à la découverte de molécules et de processus moléculaires qui régissent la formation, le maintien et la dégradation des cicatrices dans les organes solides malades, en se concentrant particulièrement sur la biologie des myofibroblastes, les principaux régulateurs cellulaires de la fibrose. L'adresse principale du groupe est Newcastle University, Newcastle Upon Tyne, Newcastle NE24HH, GB.
Le Newcastle Fibrosis Research Group est fier de ses collaborations nationales et internationales, favorisant des relations de confiance et fructueuses avec des entités publiques et privées dans le cadre de divers projets de recherche. Cette approche collaborative améliore l'impact et la portée de la recherche innovante du groupe, contribuant de manière significative aux progrès de la recherche sur la fibrose. Le Newcastle Fibrosis Research Group reste à l'avant-garde de la compréhension et de la lutte contre la fibrose grâce à une recherche de pointe et à des efforts de collaboration.
Fort d'un engagement envers l'excellence et l'innovation, Le Newcastle Fibrosis Research Group continue de faire progresser la recherche sur la fibrose. Grâce à la recherche et à la collaboration continues, le groupe vise à développer des traitements et des thérapies efficaces pour les maladies fibrotiques, améliorant ainsi la vie des patients du monde entier. Nous invitons le responsable du Newcastle Fibrosis Research Group à créer une vitrine d'entreprise et une liste de produits personnalisées et exclusives sur notre plateforme afin d'amplifier davantage votre visibilité et votre impact.
Compare Newcastle Fibrosis Research Group with 3 companies in Research-Services
| Comparison Field |
Newcastle Fibrosis Resear...Main Company |
Centre for Genomic R...View Profile |
Ce
CelgeneView Profile |
DC Chemicals LimitedView Profile |
|---|---|---|---|---|
|
Founded Year
|
— | 2000 | 2006 | |
|
Company Size
|
— | 501-1,000 | 5,001-10,000 | 51-200 |
|
City
|
Newcastle Upon Tyne, Newcastle | Barcelona, Barcelona | Summit, New Jersey | Shanghai, Shanghai |
|
Country
|
United Kingdom | Spain | United States | China |
|
Skills & Keywords
Comparing with main company
|
18 Total Skills
Fibrosis Research
Myofibroblasts
Organ Fibrosis
Molecular Processes
Scar Degradation
Newcastle University
Medical Research
Fibrosis
Epigenetics
Cancer
Technology development
Chronic liver diseases
Lung Fribrosis
Transcriptional Research
Public engagement
Drug discovery
Academic research
Industrial collaborations
|
10 Total
10 Unique
Unique Skills:
Basic research
Bioinformatics
Biomedicine
Cell Biology
Gene Regulation
Genomics
+4
|
11 Total
11 Unique
Unique Skills:
biopharma
Hematology
Immunology
Immunooncology
Inflammation
Innovation
+5
|
8 Total
8 Unique
Unique Skills:
Apoptosis和Stem Cells
Inhibitor Kits
Kinase Inhibitors
Knock-in & Knock-out Rat Services
Mycoplasma Removal Kit
Natural Products
+2
|
Other organizations in the same industry
This company is also known as